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Abstract 
Background: Performing magnetic resonance imaging (MRI) in children is a 
matter of concern and needs adequate sedation because patients should be 
completely motionless to provide a good quality of imaging. The aim of this 
study was to compare the effects of Sodium thiopental and Propofol + 
Lidocaine to provide sedation in children undergoing brain MRI. 
Methods and materials: This was a randomized, blinded trial including 250 
patients aged 3 months to 13 years who were candidate for elective brain MRI. 
Participants were divided into two groups. Group 1 received Sodium 
thiopental and group 2 received Propofol + Lidocaine. Demographic 
characteristics were recorded. Unconsciousness time, scan time and discharge 
time were compared between the two groups. Data was analyzed using SPSS 
version 16 by Chi-square, ANOVA, Man-Whitney and T-test (p<0.05). 
Results: Totally 250 patients were assigned randomly to two groups of 
Propofol + Lidocaine and Sodium thiopental, each including 125 patients. 
There was no meaningful difference regarding demographic factors of age, 
gender or ASA class between the two groups. There was no meaningful 
statistically difference regarding unconsciousness time (P value=0.655), scan 
time (P value=0.324) and discharge time (P value=0.436) between the 
Propofol + Lidocaine and Sodium thiopental group. Some minor adverse 
effects occurred in the Propofol + Lidocaine group. No major complication 
occurred.  
Conclusion: Sodium thiopental was superior to Propofol + Lidocaine 
regarding lower adverse effects, lower costs, no need for an infusion pump and 
not lowering seizure threshold.it can be considered safe for sedation in children 
undergoing brain MRI, especially those with a history of seizure.  
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Magnetic resonance imaging (MRI) is recently 
used widely as a safe, noninvasive and radiation-free 
procedure for patients either children or adults (1). The 
mechanism of device is to produce a magnetic field 
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140000 times of the Earth magnetic power, which 
triggers energy absorbing by the protons. The absorbed 
energy is then eliminated and produces the MRI image 
(2). 
The procedure lasts for about 10 to 30 minutes 
in a quite noisy pipe, which could be annoying for 
children or those suffering claustrophobia. These 
patients become severely agitated during the procedure 
and move their body, which disrupts the MRI image 
and produces artifacts. Therefore, patients must be stiff 
during the procedure, which is rather difficult, 
especially in children (3). Therefore, sedation in 
children with anesthetics is necessary.  
The magnetic field produced by the MRI 
machine absorbs all metal objects around it; hence, 
medical devices must have special characteristics to be 
used in the MRI room (4). Pulse oximetry, monitoring 
blood pressure, electrocardiography and any other 
device necessary for intubation should be available in 
the radiology room to provide sedation for patients. 
These devices should be compatible with the MRI 
machine (5). Magnetic resonance imaging is popular in 
children as well as adults as it provides better diagnosis 
of diseases, especially brain disorders such as seizure, 
malformations or tumors. The children who need 
imaging might also have some underlying problems 
like seizure or mental retardation, which make the 
imaging difficult.  
Many agents are used for sedation outside the 
operation room in the recent years. Some trials exist 
assessing the effect of propofol outside the operating 
room to provide sedation in children for different 
imaging. Propofol has been used intravenously in 
patients undergoing MRI (6-11). Failure of sedation in 
children depends on different factors such as the drug 
efficacy, individual characteristics unwanted 
complications. Failure of sedation in children during 
imaging has been reported as 1% to 16% in different 
studies. Complications during sedations include 
hypoxia, aspiration, emesis, respiratory distress, need 
for intubation, decreased blood oxygenation and some 
others, which have been reported as null up to 10% in 
different investigations (9-12). 
Another drug used for sedation is Sodium 
thiopental, also known as Sodium thiopental. It is a 
rapid-onset short-acting barbiturate used for general 
anesthesia or sedation. Sodium thiopental has been 
used rectally for sedation in radiologic procedures 
widely (13, 14). However, limitation for titration and 
delayed recovery time have been reported by trans-
rectal use (15, 16). Sodium thiopental is used widely in 
the operation room as intravenously to provide general 
anesthesia. However, there is limited experience about 
its use to provide sedation without intubation with 
spontaneous patient ventilation.  
 There are some reports of decreasing the 
threshold of seizure by propofol and lidocaine in 
specific doses in patients at risk of seizure (17-19). 
Therefore, there is an attempt to substitute them with 
safer medications. Hence, in the study we aimed to 
compare the effects of Propofol + Lidocaine and 
Sodium thiopental for sedation in children who 
undergo brain MRI in our center. 
Methods 
This was a randomized, blinded trial study 
including patients aged 3 months to 13 years, who were 
candidate for elective brain MRI under sedation. The 
study was performed in a private hospital on all 
patients referred from 2015 to 2019 who fulfilled the 
inclusion and exclusion criteria. Most of participants 
were those who needed assessment for epilepsy 
diagnosis, treatment or follow-up. Exclusion criteria 
were as follows; American society of anesthesiology 
(ASA) class more than 3, porphyria disease, or history 
of drug sensitivity to the agents used in this trial, those 
who did not consent to participate in the study, those 
with major organ failures who might not tolerate 
sedation, those with known history of respiratory 
failure or any disease that might threat children if 
mechanical ventilation was necessary. Also sensitivity 
to egg was another exclusion criterion.  
All patients in the study period who fulfilled the 
inclusion and exclusion criteria entered the study. A 
written informed consent was obtained from children 
guardians as well after complete explanation of the 
study protocol. 
Sedation protocol: patients were randomly allocated 
to two groups using random numbers. Group 1 
received Sodium thiopental and group 2 received 
Propofol + Lidocaine. Group 1, Sodium thiopental was 
first administered 1-3 mg/kg and patient response was 
then assessed. A repeated dose was also injected if 
needed. A 5-6 seconds apnea was occurred usually. 
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The concertation of Sodium thiopental was 
12.5mg/mL. In children, more than 20 kg, 1mg 
midazolam was injected 5 minutes before placing 
patients in MRI machine. If patient moved during the 
procedure or if the imaging lasted unusually, additional 
1-2 mg/kg Sodium thiopental was injected. Imaging 
lasted 10-20 minutes commonly and patients did not 
usually need maintenance doses during the procedure. 
In Propofol + Lidocaine group, children 
received an initial dose of 0.5-1 mg/kg mixed with 
lidocaine to alleviate patient pain due to injection. 
Propofol was diluted to one-third by distilled water. In 
addition, 0.5 mg lidocaine was added per each milliliter 
of propofol. The dose was repeated every 60 seconds 
until eyelid reflex was absent. Additional doses of 0.25 
mg/kg might be needed to reach the desirable level of 
sedation. If participants moved during the procedure, 
bolus doses of Propofol (0.5 mg/kg) were given and 
infusion rate was gradually augmented maximally up 
to 15 mg/kg per hour. Each milliliters of Lidocaine 
contained 1mg Lidocaine. Each Milliliters of Propofol 
contained 0.5 mg of Propofol. An infusion pump was 
needed for Propofol while it was not needed for 
Sodium thiopental group.  
During the sedation and all over the procedure 
patients were closely monitored by heart rate and pulse 
oximetry. In addition, blood pressure was measured 
three times before the procedure, after the procedure 
and before discharge. Respiratory rate was counted 4-
5 times during the procedure. The level of sedation was 
accepted if the imaging was performed with a good 
quality and without participant movement. The 
procedure was failed if the patient did not reach a 
desirable level of sedation or major complications such 
as hypoxia, bradycardia, apnea or hypotension 
occurred. We had no infusion pump compatible with 
MRI machine, therefore, the infusion pump was kept 
out of the room and an infusion extension line was 
used. 
An expert anesthesiologist in the field of 
pediatrics and an anesthesiology technician performed 
all the stages mentioned above and provided care for 
participants to avoid any complication such as 
decreased O2Sat, airway problems, etc. All devices of 
mechanical ventilation were also present if needed. 
After the end of procedure, children were discharged if 
complete consciousness was returned, O2Sat was 
desirable, blood pressure was acceptable and no 
complication present.  
Data collection: a questionnaire was filled with the 
help of participants’ parents including age, gender, and 
medical history, reason for admission, presence of 
neurological deficit, drug history and reason for 
imaging. Some other variables were recorded 
including the time elapsed from the first injected dose 
of sedative drug to complete unconsciousness to 
perform the imaging as unconsciousness time (UT). In 
addition, the scan time (ST) was the time between 
placing the participant on the MRI machine table until 
the end of procedure. The time between the end of 
imaging and participant discharge was also recorded as 
discharge time (DT).  
Data analysis: SPSS software version 16 (IBM 
Chicago, The USA) was used to analyze data. A 
Kolmogorov–Smirnov test was used to check 
normality of data. Descriptive and analytics statistics 
were used. Chi-2, Student T-test, Man Whitney and 
ANOVA used where appropriate. A p value less than 
0.05 was considered as statistically significant 
difference. 
Results 
Totally 250 patients were assigned randomly to 
two groups of Propofol + Lidocaine and Sodium 
thiopental. The study flow chart presented in flowchart 
1.  
We used a random table of numbers to al locate 
patients in the two groups. The efficacy of 
randomization was assessed by comparing the 
demographic factors between the two groups. There 
was no meaningful difference regarding demographic 
factors of age, gender, ASA class between the two 
groups as shown in Table 1.  
Mean used dosage of Sodium thiopental was 4-
5 mg/kg and for Propofol 1-2 mg/kg. No major adverse 
event occurred in our patients and all the participants 
completed the study protocol. There was no 
meaningful statistically difference regarding 
unconsciousness time between the Propofol + 
Lidocaine compared to the Sodium thiopental group (P 
value=0.655). There was no meaningful statistically 
difference regarding scan time between the Propofol + 
Lidocaine compared to the Sodium thiopental group (P 
value=0.324). There was no meaningful statistically 
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difference regarding discharge time between the 
Propofol + Lidocaine compared to the Sodium 
thiopental group (P value=0.436). Unconsciousness 
time, scan time and discharge time of participants in 
the two groups are shown in Table 2. 
Twenty-one patients (16.8%) in the Propofol+ 
Lidocaine group had some minor compilations during 
the procedure. Sixteen patients (12.8%) experienced 
temporary decrease in blood pressure and 5 (4%) 
experienced respiratory depression. Chin tilt and jaw 
thrust maneuvers together with oxygenation was 
enough to reverse respiratory depression. Fortunately, 
no patient needed intubation. In addition, those who 
experienced decreased blood pressure were managed 
with serum therapy and no patient excluded from the 
analyses.  
In the Sodium thiopental group no major 
adverse events were found, however, some participants 
experienced minor complications as nausea, dizziness, 
tinnitus, headache, transient myoclonus, which were 
managed with anti-emetics. 
 
Discussion 
Our results demonstrated no significant 
difference regarding unconsciousness time, scan time 
and discharge time between the two groups and both 
sedation protocol provided the same efficacy to 
perform the imaging. However, Propofol + Lidocaine 
needed an infusion pump, while Sodium thiopental did 
not. However, seizure like phenomenon (SLP) has 
been reported as one of the complications of Propofol 
in the literature (20). In a systematic review by Walder 
et al, it was concluded that SLP may occur in patients 
receiving Propofol with or without a history of 
epilepsy. They suggested that a change in cerebral 
Table 1: Demographic Characteristics of the Study Population. 
 
 Propofol group 
N=125 
Sodium thiopental group 
N=125 
P value 
Age, Mean ± SD, Year 6.3 ± 2.6 6.4 ± 1.7 0.566 
Gender, Male 70 (125) 68 (125) 0.444 
ASA class 1 89 88 0.711 
ASA class 2 26 28 0.536 
ASA class 3 10 9 0.632 
Number of patients with cognitive disorders 7 5 0.433 
 
Table 2: Duration of Sedation in the Both Groups. 
 
 Propofol group Sodium thiopental group P value 
Unconsciousness time1, seconds 17 ± 3.4 19 ± 2.2 0.655 
Scan time2, min 19.34 ± 4.5 20.15 ± 5.21 0.324 
Discharge time3, min 28.45 ± 5.2 30.43 ± 4.6 0.436 
1. The time between the first injections of medications till readiness to put the patient on the MRI machine 
2. Total time of imaging in the machine 
3. The time between the end of imaging and readiness for discharge 
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concentration of propofol may be causal in such a 
phenomenon (20). It is also suggested that Propofol 
might induce temporal lobe epilepsy, however, there 
are still few evidences to support this (21, 22). As our 
study included some patients who had a history of 
epilepsy, Propofol should be administered with 
caution.  
However, in another study, it was shown that 
propofol possesses significant seizure-shortening 
characteristics and does not elevate seizure threshold 
in patients with schizophrenia who underwent 
electroconvulsive therapy compared to Etomidate (23). 
In a case report and review of literature in 2019 by Lu 
et al, A 16-year-old Chinese girl know to have benign 
epilepsy with centrotemporal spikes underwent general 
anesthesia during a plastic surgery procedure and 
developed refractory status epilepticus induced by 
propofol. They suggested being aware of propofol for 
patients with a history of seizure as well (24). 
In another systematic review by Sutherland, 
 
Figure 1. The Study Flowchart. 
Mesbah Kiaei and Jafarieh Intravenous Drug Sedation for Performing MRI in Children; a Randomized Controlled Trial 
 Journal of Cellular & Molecular Anesthesia (JCMA) 
126 
they mentioned that despite anticonvulsant activity of 
propofol, it might produce an involuntary movement 
disorder, in certain patients. They mentioned that while 
propofol is proven as a very good medication, 
convulsive phenomena create a degree of concern 
about its use in some patients, especially in those with 
a history of seizures (17). 
Moreover, lidocaine is administered 
concurrently with propofol to reduce its pain. There are 
some reports showing that lidocaine might also induce 
seizure in some cases. In a study by DeToledo et al., 
concentration-dependent effect of lidocaine on 
seizures has been proposed. They reported that 
lidocaine at concentrations above 5 μg/mL might 
provoke seizures. However, lower does could suppress 
clinical and electroencephalographic manifestations of 
seizures (19). Therefore, combining propofol and 
lidocaine might not be suggested in children with a 
history of seizures. Despite the fact, in our study, we 
had no report of provoking seizures in the Propofol + 
Lidocaine group. 
On the other hand, Sodium thiopental has been 
used for sedation during imaging in many studies. 
Yunus O. Atalay et al. studied the effects of 
intravenous thiopental for sedation during magnetic 
resonance imaging in pediatric patients. A total of 300 
(American Society of Anesthesiology I–II status) 
pediatric patients received IV thiopental for sedation 
during MRI. They found that IV thiopental is an 
effective, safe, and inexpensive medication for 
sedation in children undergoing MRI (25). 
In another investigation, propofol, thiopentone 
and ketamine were compared for pediatric MRI 
sedation. This study concluded that thiopentone plus 
ketamine combination resulted in lower repetition rate 
while propofol plus ketamine offers shorter recovery 
period. However, respiratory distress was reported to 
be almost similar (26). It is consistent with our results 
that patients in the Sodium thiopental group did not 
need repetitive doses of medication; however, those in 
the Propofol + lidocaine needed an infusion pump for 
sedation maintenance. Due to lower half-life of 
Propofol, patients were ready for discharge earlier; 
despite the fact, there was no meaningful difference 
between the two groups regarding discharge time in 
our study.  
In another investigation, sedative effects of 
midazolam-ketamine combination and thiopental in 
pediatric patients undergoing magnetic resonance 
imaging were assessed and it was concluded that 
thiopental was a safe alternative to Midazolam plus 
ketamine combination for sedation during MRI. High 
image quality, anesthesia induction time and short 
recovery time make Sodium thiopental as a safe and 
cost-benefit medication to provide adequate sedation in 
children undergoing imaging (27). This is also in line 
with our study showing the superiority of Sodium 
thiopental due to its very few adverse effects and low 
costs.  
In our study, there was no meaningful 
statistically significant difference regarding discharge 
time and unconsciousness time between Propofol and 
Sodium thiopental. Besides, the total cost of a mixture 
of lidocaine and propofol was much higher than 
Sodium thiopental. It also suggests the superiority of 
Sodium thiopental to propofol.  
There were some limitations in our 
investigation. Firstly, the physician who administered 
propofol or Sodium thiopental was not blinded to the 
study groups, which might affect assessing the results, 
i.e. they might have recorded complications related to 
each group with bias, however, it was tried to be 
avoided. Second, we only compared Propofol and 
Sodium thiopental and other medications in other 
studies were not assessed. It is suggested to perform 
larger studies comparing other medications as well.  
 
Conclusion 
Sodium thiopental was superior to Propofol + 
Lidocaine regarding lower adverse effects, lower costs, 
and no need for an infusion pump and not lowering 
seizure threshold. Therefore, it can be considered for 
sedation in children undergoing brain MRI, especially 
those with a history of seizure. 
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